Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Oct 8;11(10):1503. doi: 10.3390/cancers11101503

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Pre-interventional sarcopenia is associated with a reduced overall survival after TACE. (A) Patients with a pre-interventional PMI below the 50th percentile show a trend towards an impaired prognosis. (B) Kaplan-Meier curve analysis shows a significantly reduced overall survival for sarcopenic patients with a pre-interventional PMI below 13.39 mm/m^2. The median OS in this group was 491 days (16.4 month) compared to 1291 days (43 month) in patients with a PMI above this ideal cut-off value. (C) Patients with a low combined PMI*albumin score show a strikingly reduced overall survival of 234 days (7.8 month).